(ABL) Abacus Life - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US00258Y1047

ABL: Life, Insurance, Policies, Management, Services, Technology

Abacus Global Management, Inc. (NASDAQ:ABL) is a U.S.-based alternative asset manager and market maker specializing in life insurance settlements and related financial services. The company operates through five distinct business segments: Active Management, Originations, Asset Management, Portfolio Servicing, and Technology Services. The Active Management division focuses on acquiring, trading, and holding life insurance policies until death benefits are received. The Originations segment facilitates transactions between investors and policy sellers, often involving the original policyholders. Asset Management provides investment services for alternative assets and equity funds, while Portfolio Servicing delivers policy administration support. The Technology Services division offers real-time solutions for mortality verification and missing participant searches, tailored to the life insurance industry. The company distributes its products through financial advisors, direct-to-consumer channels, and traditional life settlement intermediaries. Formerly known as Abacus Life, Inc., the firm rebranded as Abacus Global Management, Inc. in February 2025. Founded in 2004, it is headquartered in Orlando, Florida.

Based on the provided data, the stock is currently trading at $8.20, with a 20-day moving average of $7.99 and a 200-day moving average of $8.58. The average true range (ATR) of 0.45 indicates moderate volatility. The forward P/E ratio of 10.57 suggests expectations of future earnings growth, while the price-to-book ratio of 1.86 reflects a premium over book value. The negative return on equity (-8.68%) highlights current profitability challenges. Given the technical indicators, the stock may face near-term resistance around the 200-day moving average. However, the forward P/E ratio and market cap of $787.90M suggest investor confidence in the companys growth potential. The low ATR and stable moving averages indicate a relatively calm trading environment, but the negative RoE warrants caution. Overall, the stock is positioned for potential upside, provided the company improves profitability metrics.

Additional Sources for ABL Stock

ABL Stock Overview

Market Cap in USD 791m
Sector Financial Services
Industry Insurance - Life
GiC Sub-Industry Insurance Brokers
IPO / Inception 2020-09-14

ABL Stock Ratings

Growth Rating -35.9
Fundamental -
Dividend Rating 0.0
Rel. Strength -43.2
Analysts 4.75/5
Fair Price Momentum 7.27 USD
Fair Price DCF -

ABL Dividends

No Dividends Paid

ABL Growth Ratios

Growth Correlation 3m 48.4%
Growth Correlation 12m -82.1%
Growth Correlation 5y -12.5%
CAGR 5y -3.19%
CAGR/Max DD 5y -0.07
Sharpe Ratio 12m -1.11
Alpha -39.10
Beta 0.689
Volatility 24.68%
Current Volume 420.6k
Average Volume 20d 380.9k
What is the price of ABL stocks?
As of May 10, 2025, the stock is trading at USD 8.38 with a total of 420,592 shares traded.
Over the past week, the price has changed by +1.58%, over one month by +26.20%, over three months by +9.97% and over the past year by -30.46%.
Is Abacus Life a good stock to buy?
Probably not. Based on ValueRay Analyses, Abacus Life (NASDAQ:ABL) is currently (May 2025) not a good stock to buy. It has a ValueRay Growth Rating of -35.89 and therefor a somwhat technical negative rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ABL as of May 2025 is 7.27. This means that ABL is currently overvalued and has a potential downside of -13.25%.
Is ABL a buy, sell or hold?
Abacus Life has received a consensus analysts rating of 4.75. Therefor, it is recommend to buy ABL.
  • Strong Buy: 3
  • Buy: 1
  • Hold: 0
  • Sell: 0
  • Strong Sell: 0
What are the forecast for ABL stock price target?
According to ValueRays Forecast Model, ABL Abacus Life will be worth about 7.9 in May 2026. The stock is currently trading at 8.38. This means that the stock has a potential downside of -5.25%.
Issuer Forecast Upside
Wallstreet Target Price 13.6 62.3%
Analysts Target Price 13.9 65.6%
ValueRay Target Price 7.9 -5.3%